Abstract
The interaction of a designed bioactive lipopeptide C16-GGGRGDS, comprising a hexadecyl lipid chain attached to a functional heptapeptide, with the lipid-free apoliprotein, Apo-AI, is examined. This apolipoprotein is a major component of high density lipoprotein and it is involved in lipid metabolism and may serve as a biomarker for cardiovascular disease and Alzheimers' disease. We find via isothermal titration calorimetry that binding between the lipopeptide and Apo-AI occurs up to a saturation condition, just above equimolar for a 10.7 μM concentration of Apo-AI. A similar value is obtained from circular dichroism spectroscopy, which probes the reduction in α-helical secondary structure of Apo-AI upon addition of C16-GGGRGDS. Electron microscopy images show a persistence of fibrillar structures due to self-assembly of C16-GGGRGDS in mixtures with Apo-AI above the saturation binding condition. A small fraction of spheroidal or possibly "nanodisc" structures was observed. Small-angle X-ray scattering (SAXS) data for Apo-AI can be fitted using a published crystal structure of the Apo-AI dimer. The SAXS data for the lipopeptide/Apo-AI mixtures above the saturation binding conditions can be fitted to the contribution from fibrillar structures coexisting with flat discs corresponding to Apo-AI/lipopeptide aggregates.
Highlights
Apolipoproteins are proteins that bind lipids, and are involved in lipid transport in vivo
A similar value is obtained from circular dichroism spectroscopy, which probes the reduction in α-helical secondary structure of Apolipoprotein A-I (Apo-AI) upon addition of C16-GGGRGDS
The relatively low Apo-AI concentration selected for Isothermal titration calorimetry (ITC) reduces the total number of binding sites to ensure saturation of C16GGGRGDS binding to Apo-AI is reached
Summary
Apolipoproteins are proteins that bind lipids, and are involved in lipid transport in vivo. There are six classes of apolipoprotein with different structures and biological activities. The apoliprotein A family is a major component of high density lipoprotein (HDL). HDL removes fat and cholesterol from cells and there is significant research interest in the interaction of Apo-A apolipoproteins with lipids due to biomedical relevance, in particular to cardiovascular disease. Among this class, Apo-AI is the major component of HDL, comprising 70% of total protein.[1] Polymorphism in the gene associated with Apo-AI has been associated with early onset Alzheimer’s disease.[2]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have